Compare CVS Health Corp (CVS) vs Hormel Foods Corp (HRL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Hormel Foods Corp — how do they compare? CVS Health Corp trades at $93.7 (market cap $122.36B), while Hormel Foods Corp trades at $24.54 (market cap $13.59B). The key difference: CVS Health Corp is far larger — about 9× Hormel Foods Corp's market cap, and Hormel Foods Corp pays the higher dividend (4.74%). Which is the better fit depends on your goals.
| CVS | HRL | |
|---|---|---|
Market Cap | $122.36B | $13.59B |
Sector | Health | Consumer Staples |
52-Week High | $110.60 | $29.25 |
52-Week Low | $65.51 | $19.74 |
Enterprise Value | $184.71B | $15.59B |
Dividend Yield | 2.78% | 4.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
Hormel Foods (HRL) trades at $25.02, down 0.32% on the day, with a neutral technical signal and bearish moving averages. The company shows mixed fundamentals with a P/E of 29.44 and net income margin of 3.82%, though it has beaten earnings estimates for three consecutive quarters. Recent developments include the appointment of John Ghingo as CEO and the sale of its Brazilian CERATTI business, signaling strategic focus.
Outlook remains cautious with analyst consensus at Hold and a $26.33 price target. Key opportunities include defensive dividend income and operational improvements, while risks involve margin pressure and consumer spending challenges. The stock offers steady income but faces growth headwinds in the current environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Hormel Foods Corp
Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Read more on HRL →
